HCAT

Health Catalyst

• PUBT·05/19 20:16

  Health Catalyst announces annual shareholder meeting webcast

• TipRanks·05/19 17:25

  Health Catalyst: Buy Rating Reaffirmed as Strategic Transformation Supports Long-Term Growth Despite Near-Term Estimate Cuts

• Simply Wall St·05/13 00:46

  Health Catalyst (HCAT) Trailing EPS Loss Worsens And Reinforces Bearish Profitability Narratives

• TipRanks·05/13 00:27

  Health Catalyst Earnings Call Maps Costly Transition

• TipRanks·05/12 13:47

  Health Catalyst (HCAT) Gets a Hold from Stifel Nicolaus

• Benzinga·05/12 13:35

  Stephens & Co. Maintains Equal-Weight on Health Catalyst, Lowers Price Target to $1.75

• Dow Jones·05/12 13:34

  Health Catalyst Is Maintained at Equal-Weight by Stephens & Co.

• Dow Jones·05/12 13:34

  Health Catalyst Price Target Cut to $1.75/Share From $2.00 by Stephens & Co.

• TipRanks·05/12 12:25

  Health Catalyst: Buy Rating Reiterated on Project Nexus Progress, Margin Upside, and Unchanged $2 Price Target

• TipRanks·05/12 11:52

  Health Catalyst price target lowered to $1.75 from $2 at Stephens

• TipRanks·05/12 10:50

  Analysts Offer Insights on Healthcare Companies: Dyne Therapeutics (DYN), Health Catalyst (HCAT) and Gain Therapeutics (GANX)

• TipRanks·05/12 10:20

  Analysts Offer Insights on Healthcare Companies: Chugai Pharmaceutical Co (OtherCHGCF), Liquidia Technologies (LQDA) and Health Catalyst (HCAT)

• Seeking Alpha·05/12 10:02

  Health Catalyst outlines $260M-$265M 2026 revenue outlook backed by Project Nexus $30M run-rate savings

• TipRanks·05/12 10:01

  Analysts Offer Insights on Healthcare Companies: Health Catalyst (HCAT), Liquidia Technologies (LQDA) and Bicara Therapeutics Inc. (BCAX)

• TipRanks·05/11 23:40

  Analysts Offer Insights on Healthcare Companies: Health Catalyst (HCAT) and Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF)